Test Price
450 AED✅ Home Collection Available
Immunohistochemistry LIN-28 Test in UAE | 450 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval for archival FFPE blocks and biopsy slides.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LIN-28 immunohistochemistry test is a precision tissue-staining assay that identifies the LIN-28 protein – a master stem‑cell marker – in formalin‑fixed tumor biopsies. Designed for surgical pathologists, oncologists and anti‑aging specialists, it enables the accurate subclassification of aggressive germ cell tumors, neuroendocrine carcinomas and poorly differentiated malignancies, directly informing targeted therapy decisions.
| Feature | Our LIN-28 Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity using a clinically validated LIN-28 antibody clone | Standard H&E stain – no stem‑cell marker specificity |
| Methodology | Automated IHC with internal positive and negative controls | Conventional histopathology without LIN-28 interrogation |
| Turnaround | 5 – 7 working days for tissue blocks or biopsies | 3 – 5 days (morphology only) |
Sample requirements: Submit tumor tissue in 10% formal‑saline OR a formalin‑fixed paraffin‑embedded block. Ship at room temperature. Provide a copy of the Histopathology report, biopsy site and full clinical history.
Physician Insight & Safety Protocols
“Waiting for a tissue diagnosis is deeply unsettling. The LIN-28 immunohistochemistry test provides critical clarity into the tumor’s biological identity, helping differentiate aggressive subtypes that demand urgent oncological intervention. It is essential that every laboratory finding is interpreted alongside the full clinical history and imaging data.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory: Medication Continuity
⚠️ Do not discontinue any prescribed medication without consulting your treating physician.
Exclusion Criteria & Emergency Red Flags
- Minors (under 18) without the presence of a legal guardian – informed consent must be obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Known bleeding disorder or current anticoagulant/thrombolytic therapy that cannot be safely paused.
- Active infection or severe inflammation at the planned biopsy site.
- Red Flags – Seek Immediate Hospital Attention: Rapidly expanding mass, uncontrolled pain, active bleeding from the lesion, or signs of systemic infection (fever, chills, confusion).
Patient FAQ & Clinical Guidance
1. What exactly does the LIN-28 test detect, and why is it required?
The LIN-28 IHC directly visualizes the LIN-28 protein in tumour tissue, enabling precise classification of germ cell and neuroendocrine malignancies.
This marker helps distinguish embryonal carcinomas, yolk sac tumors, gonadoblastomas and high‑grade neuroendocrine carcinomas from other neoplasms, which directly influences treatment selection.
2. How should I prepare, and what sample is needed?
A tissue biopsy already preserved in formalin – as a paraffin block or wet specimen – is required; no fasting or medication changes are needed.
Your physician will provide the histopathology report, biopsy site details and clinical history. Our courier service will retrieve the archival specimen following secure medical transport protocols.
3. When will I receive the report, and what do the results mean?
Report is typically issued within 5–7 working days; a positive LIN-28 stain indicates aggressive tumour features that require integrated oncological interpretation.
A positive result points toward certain germ cell or neuroendocrine differentiation, guiding the selection of chemotherapy, targeted agents or surgical approaches. Your oncologist will correlate the finding with radiology and clinical history to create a personalized care plan.
UAE Regulatory & Data Privacy Adherence
This medical diagnostic service is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing patient data confidentiality and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields regulating health information systems. All clinical testing, specimen handling and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure patient safety and legal compliance.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry LIN-28 (LIN-28 IHC) |
| Price (AED) | 450 AED |
| Turnaround Time | 5 – 7 working days |
| Sample Type / Matrix | Archival Tissue Specimen (FFPE Tissue Block or Biopsy Slides) |
| Methodology Used | Automated Immunohistochemistry (IHC) with internal positive and negative controls |
| ICD-10-CM Code | C62.90 |
| LOINC Code | 94477-3 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians